← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Phagepro, Inc.
Mansfield, MA
$5,199,327
Total funding
5
Grants
Funding over time
peak $1.2M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,199,327 · 5
By mechanism
R44$3,904,818 · 2
R41$738,041 · 1
R21$383,168 · 1
R34$173,300 · 1
Investigators at Phagepro, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail$1,000,000
R44 · FY2025 · AI
Product optimization to commercialize an oral bacteriophage cocktail that prevents cholera in real-world settings$999,585
R44 · FY2021 · AI
Product optimization to commercialize an oral bacteriophage cocktail that prevents cholera in real-world settings$975,187
R44 · FY2022 · AI
Product optimization to commercialize an oral bacteriophage cocktail that prevents cholera in real-world settings$930,046
R44 · FY2023 · AI
Developing a Scalable Manufacturing Process for an Oral Bacteriophage Product that Prevents Cholera$300,000
R41 · FY2020 · AI
Developing a Scalable Manufacturing Process for an Oral Bacteriophage Product that Prevents Cholera$300,000
R41 · FY2019 · AI
Targeting antibiotic resistance genes in Vibrio cholerae using a phage-encoded CRISPR-Cas system to improve efficacy of phage prophylaxis$204,527
R21 · FY2022 · AI
Targeting antibiotic resistance genes in Vibrio cholerae using a phage-encoded CRISPR-Cas system to improve efficacy of phage prophylaxis$178,641
R21 · FY2021 · AI
Preparation of a Phase I/II safety and efficacy trial for a cholera phage cocktail intervention$173,300
R34 · FY2024 · AI
Developing a Scalable Manufacturing Process for an Oral Bacteriophage Product that Prevents Cholera$83,041
R41 · FY2020 · AI
Developing a Scalable Manufacturing Process for an Oral Bacteriophage Product that Prevents Cholera$55,000
R41 · FY2020 · AI